title: Macrophage activation syndrome associated with co-trimoxazole.
authors.affiliation: Faculté de Médecine, Université Aix-Marseille, Institut Hospitalo-Universitaire Méditerranée Infection, 27 Boulevard Jean-Moulin, 13385 Marseille Cedex 5, France.
authors.forename: M
authors.initials: M
authors.lastname: Vernier
authors.forename: M
authors.initials: M
authors.lastname: Million
authors.forename: D
authors.initials: D
authors.lastname: Laugier
authors.forename: T
authors.initials: T
authors.lastname: Le Treut
authors.forename: P
authors.initials: P
authors.lastname: Brouqui
authors.forename: E
authors.initials: E
authors.lastname: Botelho-Nevers
mesh_terms: D018784:Abdominal Abscess / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D006801:Humans; D008262:Macrophage Activation / Q000187:drug effects; D055501:Macrophage Activation Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D010000:Osteitis / Q000188:drug therapy / Q000382:microbiology; D011631:Pubic Symphysis / Q000293:injuries / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000627:therapeutic use; D014946:Wound Infection / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination